What Kestra Medical Technologies, Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 34 | 53 |
| Total trades | 45 | 79 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 252,802 | 843,259 |
| Disposed | 443,651 | 601,928 |
| Net activity | −190,849 | +241,331 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mahboob Vaseem | Chief Financial Officer | Oct 29 | Open-market sale · S | −4,788 | $30.60 | −$147K | 60,609 |
| Mahboob Vaseem | Chief Financial Officer | Oct 29 | Exercise / conversion · M | +4,788 | $17.00 | +$81.4K | 65,397 |
| Mahboob Vaseem | Chief Financial Officer | Oct 28 | Open-market sale · S | −39,903 | $30.48 | −$1.22M | 60,609 |
| Mahboob Vaseem | Chief Financial Officer | Oct 28 | Exercise / conversion · M | +39,903 | $17.00 | +$678K | 100,512 |
| Mahboob Vaseem | Chief Financial Officer | Oct 27 | Open-market sale · S | −34,809 | $30.04 | −$1.05M | 60,609 |
| Mahboob Vaseem | Chief Financial Officer | Oct 27 | Exercise / conversion · M | +34,809 | $17.00 | +$592K | 95,418 |
| Umberger Traci S | See Remarks | Oct 27 | Open-market sale · S | −30,000 | $30.03 | −$901K | 195,825 |
| Umberger Traci S | See Remarks | Oct 27 | Exercise / conversion · M | +30,000 | $17.00 | +$510K | 225,825 |
| Umberger Traci S | See Remarks | Oct 21 | Open-market sale · S | −3,596 | $28.09 | −$101K | 195,825 |
| Umberger Traci S | See Remarks | Oct 21 | Open-market sale · S | −96,404 | $27.15 | −$2.62M | 199,421 |
| Umberger Traci S | See Remarks | Oct 21 | Exercise / conversion · M | +100,000 | $17.00 | +$1.7M | 295,825 |
| Webster Brian Daniel | See Remarks | Oct 20 | Open-market sale · S | −1,684 | $29.89 | −$50.3K | 445,215 |
| Webster Brian Daniel | See Remarks | Oct 20 | Open-market sale · S | −13,316 | $29.52 | −$393K | 446,899 |
| Cohen Raymond W | Director | Sep 30 | Open-market sale · S | −3,330 | $29.28 | −$97.5K | 54,790 |
| Kwo Elizabeth | Director | Sep 21 | Open-market sale · S | −4,010 | $24.26 | −$97.3K | 14,116 |
| Ladone Mary Kay | Director | Sep 09 | Grant / award · A | +7,217 | — | — | 44,724 |
| Reilly Kevin C | Director | Sep 09 | Grant / award · A | +7,217 | — | — | 12,585 |
| Cohen Raymond W | Director | Sep 09 | Grant / award · A | +7,217 | — | — | 58,120 |
| Schwartz Jeffrey Lawrence | Director | Sep 09 | Grant / award · A | +7,217 | — | — | 14,236 |
| Kwo Elizabeth | Director | Sep 09 | Grant / award · A | +7,217 | — | — | 18,126 |
Loading...